Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-25

Clinical Trial Update: Protective Effect of Biodegradable Collagen Implant (Ologen) in Scleral Thinning After Strabismus Surgery [NA]

View source ↗

Summary

This clinical trial update evaluates whether the biodegradable collagen implant Ologen protects the sclera after strabismus surgery in patients with exotropia, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ologen

Snippet

Sponsor: Yonsei University | Conditions: Exotropia or Intermittent Exotropia | NA | Status: COMPLETED